Company performance
Current Price
as of Jan 07, 2025$124.49
P/E Ratio
103.41
Market Cap
$11.89B
Description
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Metrics
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerSRPT
- Price$124.49-2.66%
Trading Information
- Market cap$11.89B
- Float93.75%
- Average Daily Volume (1m)646,254
- Average Daily Volume (3m)926,354
- EPS$1.29
Company
- Revenue$1.64B
- Rev growth (1yr)40.79%
- Net income$33.61M
- Gross margin78.27%
- EBITDA margin7.78%
- EBITDA$36.33M
- EV$12.74B
- EV/Revenue7.77
- P/E103.41
- P/S7.62
- P/B9.74
Documents
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia